TY  - GEN
AU  - Bradstock,K
AU  - Matthews,J
AU  - Young,G
AU  - Lowenthal,R
AU  - Baxter,H
AU  - Arthur,C
AU  - Bashford,J
AU  - Brighton,T
AU  - Cannell,P
AU  - Dunlop,L
AU  - Durrant,S
AU  - Enno,A
AU  - Eliadis,P
AU  - Gill,D
AU  - Gillett,A
AU  - Gottlieb,D
AU  - Januszewicz,H
AU  - Joshua,D
AU  - Leahy,M
AU  - Schwarer,A
AU  - Taylor,K
TI  - Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia
SN  - 0887-6924
PY  - 2001///0906
KW  - Acute Disease
KW  - Adjuvants, Immunologic
KW  - economics
KW  - Adult
KW  - Cost-Benefit Analysis
KW  - Cytarabine
KW  - administration & dosage
KW  - Female
KW  - Glycosylation
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Idarubicin
KW  - Lenograstim
KW  - Leukemia, Myeloid
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Recombinant Proteins
KW  - Survival Rate
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.leu.2402218
ER  -